Ourfindings lay the groundwork for future studies on full-length andhyperphosphorylated Tau constructs and the influence of higher modificationstoichiometries on Tau aggregation, which could further elucidatethe pathogenesis of Alzheimer’s disease and related tauopathies. The gene discussed is MAPT; the disease is tauopathy.